Search

Plasticity with cochlear implants: individual factors in the outcomes

Andrej Kral gives us an overview of neuronal plasticity in congenital hearing loss, and discusses why it is core to our clinical interventions in hearing loss and rehabilitation. The brain is born immature and undergoes extensive shaping during early development....

Measuring client-centred outcomes in audiology: towards a parsimonious solution

From an international driver to the client-centred care model; in this article Anthony Hogan explores outcome measures for individual goal setting and measuring those outcomes. Introduction When people present for hearing help, they are typically looking for solutions to the...

Hearing, tinnitus and hyperacusis in the arts

Hearing loss, tinnitus and hyperacusis are discussed by David Baguley from the unique perspective of their depictions in literature, music, film and paintings. This article provides unusual and invaluable reflective opportunities for the patient-centred clinician! Audiologists and otologists understand hearing...

Multifrequency tympanometry

There are many good reasons to start using multifrequency tympanometry as opposed to a traditional, single 226Hz probe tone. Here, Leigh Martin of Interacoustics discusses the uses and benefits. Tympanometry is a core test in the audiologist’s test battery. In...

Speech mapping and the benefits of using in clinical practice

Fitting hearing aids is not simply a case of one size fits all. Nicole da Rocha discusses the benefits of using speech mapping as a verification tool. The verification of hearing aids has become quintessential for best practice. Using either...

Direct-to-consumer hearing devices: a need to combine cosmetic appeal with device capabilities

How safe and desirable are direct-to-consumer amplification devices? A team has put a range of devices through their paces and compared them to a standard NHS hearing device. Why do most individuals who would benefit from hearing aids not try...

Genetics and the newborn hearing screen: the future is now

Eliot Shearer shares the progress being made with newborn hearing screening 60 years on from where it started, and future directions for identifying hearing loss using physiologic, genetic and cCMV screening. Newborn screening had its birth in the early 1960s,...

Innovative approaches to treating deafness

Shahar Taiber and Karen Avraham give us a summary of gene therapies for hearing loss, with an overview of limitations and what the future holds. Hearing loss is the most common sensory disorder. The last two decades have seen a...

Hearables: in-ear sensing devices for recording of physiological signals

Colver Ken Howe Ne, Jameel Muzaffar and Manohar Bance discuss the potential of hearable systems to monitor physiological signals (e.g. from brain or heart, blood pressure, body temperature) unobtrusively. Such adaptations require high-quality sensors and sophisticated de-noising signal processing on...

Mind the gap – developing a sustainable pipeline for hearing therapeutics

In this article, the authors describe three key challenges faced in developing hearing therapeutics. Collaboration between companies, sectors and disciplines will be key to finding solutions. The unmet need for therapies for hearing loss grows apace, with prevalence rising across...

What you need to know about recent advances in genetics of hearing loss in the newborn

Identifying the underlying genetic cause of hearing loss in newborns can improve dramatically the early diagnosis and appropriate intervention. Hearing loss is the most common sensory disorder at birth, affecting approximately two out of 1000 newborns [1]. Congenital impaired hearing...